Cargando…

Potential for NPY receptor–related therapies for polycystic ovary syndrome: an updated review

Polycystic ovary syndrome (PCOS) is a complex endocrine disease that can cause female infertility and bring economic burden to families and to society. The clinical and/or biochemical manifestations include hyperandrogenism, persistent anovulation, and polycystic ovarian changes, often accompanied b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Wei-hong, Shi, Yan-chuan, Huang, Qiao-yi, Chen, Jia-ming, Wang, Zhi-yi, Lin, Shu, Shi, Qi-yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449684/ https://www.ncbi.nlm.nih.gov/pubmed/37452264 http://dx.doi.org/10.1007/s42000-023-00460-8

Ejemplares similares

Therapeutic potential of exosomes/miRNAs in polycystic ovary syndrome induced by the alteration of circadian rhythms
por: Chen, Wei-hong, et al.
Publicado: (2022)

Update on polycystic ovary syndrome
por: Kim, Jin Ju
Publicado: (2021)

An Update on Contraception in Polycystic Ovary Syndrome
por: Oguz, Seda Hanife, et al.
Publicado: (2021)

Potential genetic polymorphisms predicting polycystic ovary syndrome
por: Chen, Yao, et al.
Publicado: (2018)

Update on Animal Models of Polycystic Ovary Syndrome
por: Stener-Victorin, Elisabet
Publicado: (2022)

Receptor-specific recognition of NPY peptides revealed by structures of NPY receptors
por: Tang, Tingting, et al.
Publicado: (2022)

The Polycystic Ovary Syndrome: An update on metabolic and hormonal mechanisms
por: Dumitrescu, R, et al.
Publicado: (2015)

An update of polycystic ovary syndrome: causes and therapeutics options
por: Rababa’h, Abeer M., et al.
Publicado: (2022)

A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis
por: Wu, Jia, et al.
Publicado: (2018)

Estrogen Receptors in Polycystic Ovary Syndrome
por: Xu, Xue-Ling, et al.
Publicado: (2021)

Is interleukin-18 associated with polycystic ovary syndrome?
por: Yang, Yan, et al.
Publicado: (2011)

Markers of insulin resistance in Polycystic ovary syndrome women: An update
por: Amisi, Chantal Anifa
Publicado: (2022)

Updating the polycystic ovary syndrome diagnosis: Does ultrasound matter?
por: Komorowski, Allison S., et al.
Publicado: (2023)

Immunophenotypic Profiles in Polycystic Ovary Syndrome
por: Hu, Cong, et al.
Publicado: (2020)

NPY Receptor 2 Mediates NPY Antidepressant Effect in the mPFC of LPS Rat by Suppressing NLRP3 Signaling Pathway
por: Wang, Wenjiao, et al.
Publicado: (2019)

Hepatic steatosis in women with polycystic ovary syndrome
por: Hong, Xinyu, et al.
Publicado: (2023)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

The Application of Complementary and Alternative Medicine in Polycystic Ovary Syndrome Infertility
por: Shi, Yu-Qian, et al.
Publicado: (2022)

Update in polycystic ovary syndrome: new criteria of diagnosis and treatment in Japan
por: Kubota, Toshiro
Publicado: (2013)

Impact of updated international diagnostic criteria for the diagnosis of polycystic ovary syndrome
por: Kostroun, Katherine E., et al.
Publicado: (2022)

A PPARG Splice Variant in Granulosa Cells Is Associated with Polycystic Ovary Syndrome
por: Shi, Chao-Yi, et al.
Publicado: (2022)

Association between Polycystic Ovary Syndrome and Gut Microbiota
por: Guo, Yanjie, et al.
Publicado: (2016)

Therapeutic potential of neuropeptide Y (NPY) receptor ligands
por: Brothers, Shaun P, et al.
Publicado: (2010)

The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
por: Anala, Alekya Devi, et al.
Publicado: (2023)

The physiological functions and therapeutic potential of exosomes during the development and treatment of polycystic ovary syndrome
por: Zhang, Zhenghong, et al.
Publicado: (2023)

Potential Role of Quercetin in Polycystic Ovary Syndrome and Its Complications: A Review
por: Chen, Tong, et al.
Publicado: (2022)

Pregnancy in polycystic ovary syndrome
por: Kamalanathan, Sadishkumar, et al.
Publicado: (2013)

The inositols and polycystic ovary syndrome
por: Kalra, Bharti, et al.
Publicado: (2016)

On the Therapy for Polycystic Ovary Syndrome
por: Unfer, Vittorio, et al.
Publicado: (2017)

Kisspeptin and Polycystic Ovary Syndrome
por: Tang, Rong, et al.
Publicado: (2019)

Polycystic Ovary Syndrome in Adolescence
por: Deans, Rebecca
Publicado: (2019)

Quercetin and polycystic ovary syndrome
por: Ma, Congshun, et al.
Publicado: (2022)

Integrating network pharmacology and experimental verification to explore the pharmacological mechanisms of asparagus against polycystic ovary syndrome
por: Xing, Jinshan, et al.
Publicado: (2023)

Polycystic Ovary Syndrome: An Updated Overview Foregrounding Impacts of Ethnicities and Geographic Variations
por: Yasmin, Afrin, et al.
Publicado: (2022)

Polymorphisms in FSHR modulating susceptibility to polycystic ovary syndrome: an updated meta-analysis
por: Kaur, Mandeep, et al.
Publicado: (2023)

Androgen receptor gene mutations in 258 Han Chinese patients with polycystic ovary syndrome
por: Tian, Lifeng, et al.
Publicado: (2021)

The effect of cinnamon on polycystic ovary syndrome in a mouse model
por: Dou, Lei, et al.
Publicado: (2018)

The role of FDX1 in granulosa cell of Polycystic ovary syndrome (PCOS)
por: Wang, Zhi, et al.
Publicado: (2021)

Analysis of Endocrine and Metabolic Indexes in Non-Obese Patients with Polycystic Ovary Syndrome and Its Compare with Obese Patients
por: Shi, Wenjing, et al.
Publicado: (2021)

Identification of Three Potential circRNA Biomarkers of Polycystic Ovary Syndrome by Bioinformatics Analysis and Validation
por: Huang, Pengyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pjro2hka9rtit8k14uurvluif6